Review article: aminosalicylates in inflammatory bowel disease.
about
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's diseaseOral pathology in inflammatory bowel diseasePharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsDietary uptake of Wedelia chinensis extract attenuates dextran sulfate sodium-induced colitis in miceA new look at a mainstay ulcerative colitis therapyThiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.The role of mesalamine in the treatment of ulcerative colitis.Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease centerMesalamine with MMX technology for the treatment of ulcerative colitis.Current and future therapies for inflammatory bowel disease.Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.Assessment of isomalt for colon-specific delivery and its comparison with lactulose.Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers.Gynostemma pentaphyllum saponins attenuate inflammation in vitro and in vivo by inhibition of NF-κB and STAT3 signaling.An unusual case of mesalazine intoxication: oral and rectal overloading of the rectal suppository form.Novel Gene Encoding 5-Aminosalicylate 1,2-Dioxygenase from Comamonas sp. Strain QT12 and Catalytic Properties of the Purified Enzyme.Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: a pilot open-labeled prospective study.Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.Transcriptomic analysis reveals a controlling mechanism for NLRP3 and IL-17A in dextran sulfate sodium (DSS)-induced colitis
P2860
Q24245127-E5AF79BF-2C29-4523-A7B7-C004BBEE9956Q26739055-4E82E1FE-5CAB-43EA-A681-602C5207A605Q26768280-9A275245-1A4C-4BFF-B03C-8AAC04685435Q34755383-49A49BAE-A66A-45C3-BCC9-3E2CD0FBC89AQ34940520-52CDF4A7-16F0-4A82-B805-7BEAEE1D353EQ35221802-A67E9533-DB52-4F80-A28C-CD514A247922Q36645826-FD47A59E-44FE-40C3-B135-402D74077A7CQ36653732-3D5A93EB-7243-4AD3-8771-36259C07EF20Q37345925-070A51E5-30D7-499E-ABD4-2E141E731FD4Q37346047-2673075E-9D73-46CE-910C-6D3DFB2F5119Q38967059-89430ECD-233F-45FE-9924-9899BC094F4BQ39014759-A3BFC8B1-1F40-47EA-A95C-4F6896BF758EQ41881682-D29196A0-B784-451E-9E99-50C7637237BBQ43121315-3EAAB9C6-DE27-42A5-8B00-094D8C54B1B6Q46879612-B7635BDA-AE1C-4FDE-B7A5-6766FC289843Q47161618-24546BB4-8A17-47F6-B50C-B56B612AE2C9Q49106313-2AD9A427-DC8B-40AE-AB3B-39A6FAD65C26Q50077285-5E48FF28-AE6E-4DB9-BDFD-EC69C0DE65ADQ50448602-8501D51C-396B-4778-BEE4-45BA020C69CDQ51369344-8A9488B4-63F6-46A1-8DCE-B4012233E2E6Q54746034-BE475069-E20A-495E-B246-B14EB8FCD038Q57296225-60180EEF-CE92-4047-A6E1-0E4C297996B7
P2860
Review article: aminosalicylates in inflammatory bowel disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Review article: aminosalicylates in inflammatory bowel disease.
@ast
Review article: aminosalicylates in inflammatory bowel disease.
@en
type
label
Review article: aminosalicylates in inflammatory bowel disease.
@ast
Review article: aminosalicylates in inflammatory bowel disease.
@en
prefLabel
Review article: aminosalicylates in inflammatory bowel disease.
@ast
Review article: aminosalicylates in inflammatory bowel disease.
@en
P2860
P1476
Review article: aminosalicylates in inflammatory bowel disease.
@en
P2093
Hanauer SB
P2860
P356
10.1111/J.1365-2036.2004.02048.X
P407
P478
20 Suppl 4
P577
2004-10-01T00:00:00Z